Pleasure-Focused Harm Reduction for Chemsex and Substance Use
Part of Infections, Mental health clinical trials.
This study explores how adding conversation about sexual pleasure to harm reduction services can help men who have sex with men and transgender persons who use drugs during sex or use other substances. If you join, you may learn new ways to reduce risks while still enjoying your sex life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are a man who has sex with men, a transgender woman, a transgender man, or a non-binary person.
- You have used drugs during sex (chemsex) or used other substances in the past 12 months.
- You can communicate well enough in Thai to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores ways to support men who have sex with men (MSM) in Bangkok who use drugs during sexual activities, called 'chemsex.' Researchers want to understand how community leaders, healthcare workers, and police can work together to keep people safer and healthier.
This study tests a new support program designed specifically for transgender people who use drugs or engage in chemsex (using drugs during sexual activity). The program aims to reduce health risks and provide safer, more culturally respectful care.
This study aims to develop healthcare services tailored to transgender people regarding chemsex (using drugs during sex). Researchers will interview participants to understand their needs and experiences.
This trial tests a community support program called PARC for people who engage in chemsex. It aims to see if the program helps reduce or stop drug use and related health problems.
This study looks at how to better support young men living with or at risk for HIV while also addressing substance use. You'll work with a care team that helps you stay healthy and connected to services.
This trial tests a non-painful brain stimulation method (tDCS) to help reduce cravings related to chemsex. If you qualify, you’ll be randomly assigned to real stimulation or a sham (placebo) and complete study visits and questionnaires.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.